Skip to main content

Articles

Page 85 of 108

  1. Focal adhesion kinase (FAK) regulates multiple cellular processes including growth, differentiation, adhesion, motility and apoptosis. In breast carcinoma, FAK overexpression has been linked to cancer progress...

    Authors: Klaus Jürgen Schmitz, Florian Grabellus, Rainer Callies, Friedrich Otterbach, Jeremias Wohlschlaeger, Bodo Levkau, Rainer Kimmig, Kurt Werner Schmid and Hideo Andreas Baba
    Citation: Breast Cancer Research 2005 7:R194
  2. Few studies have examined the effect of breast implants after mastectomy on long-term survival in breast cancer patients, despite growing public health concern over potential long-term adverse health effects.

    Authors: Gem M Le, Cynthia D O'Malley, Sally L Glaser, Charles F Lynch, Janet L Stanford, Theresa HM Keegan and Dee W West
    Citation: Breast Cancer Research 2004 7:R184
  3. Breast cancer is the leading cause of cancer death in women worldwide. Elevated expression of c-Myc is a frequent genetic abnormality seen in this malignancy. For a better understanding of its role in maintain...

    Authors: Yi-hua Wang, Shuang Liu, Guo Zhang, Cui-qi Zhou, Hong-xia Zhu, Xiao-bo Zhou, Lan-ping Quan, Jin-feng Bai and Ning-zhi Xu
    Citation: Breast Cancer Research 2004 7:R220
  4. The combination of mathematics – queen of sciences – and the general utility of computers has been used to make important inroads into insight-providing breast cancer research and clinical aids. These developm...

    Authors: Michael Retsky, Romano Demicheli, William Hrushesky, John Speer, Douglas Swartzendruber and Robert Wardwell
    Citation: Breast Cancer Research 2004 7:37
  5. The androgen receptor (AR) gene exon 1 CAG repeat polymorphism encodes a string of 9–32 glutamines. Women with germline BRCA1 mutations who carry at least one AR allele with 28 or more repeats have been reported ...

    Authors: Amanda B Spurdle, Antonis C Antoniou, David L Duffy, Nirmala Pandeya, Livia Kelemen, Xiaoqing Chen, Susan Peock, Margaret R Cook, Paula L Smith, David M Purdie, Beth Newman, Gillian S Dite, Carmel Apicella, Melissa C Southey, Graham G Giles, John L Hopper…
    Citation: Breast Cancer Research 2004 7:R176
  6. Truncation mutations in the BRCA1 gene cause a substantial increase in risk of breast cancer. However, these mutations are rare in the general population and account for little of the overall incidence of sporadi...

    Authors: David G Cox, Peter Kraft, Susan E Hankinson and David J Hunter
    Citation: Breast Cancer Research 2004 7:R171
  7. Ataxia-telangiectasia is an autosomal-recessive disease that affects neuro-immunological functions, associated with increased susceptibility to malignancy, chromosomal instability and hypersensitivity to ioniz...

    Authors: Seiichi Umesako, Kae Fujisawa, Sayoko Iiga, Nobuko Mori, Masahiro Takahashi, Doo-Pyo Hong, Chang-Woo Song, Satomi Haga, Syunsuke Imai, Otsura Niwa and Masaaki Okumoto
    Citation: Breast Cancer Research 2004 7:R164
  8. Radiotherapy (RT) is considered a standard treatment option after surgery for breast cancer. Letrozole, an aromatase inhibitor, is being evaluated in the adjuvant setting. We determined the effects of the comb...

    Authors: David Azria, Christel Larbouret, Severine Cunat, Mahmut Ozsahin, Sophie Gourgou, Pierre Martineau, Dean B Evans, Gilles Romieu, Pascal Pujol and Andre Pèlegrin
    Citation: Breast Cancer Research 2004 7:R156
  9. Overexpression of the HER2/neu gene in breast cancer is associated with an increased incidence of metastatic disease and with a poor prognosis. Although passive immunotherapy with the humanized monoclonal antibod...

    Authors: Xiaoyan Wang, Jian-Ping Wang, Maureen F Maughan and Lawrence B Lachman
    Citation: Breast Cancer Research 2004 7:R145
  10. 17β-estradiol (E2) can rapidly induce cAMP production, but the conditions under which these cAMP levels are best measured and the signaling pathways responsible for the consequent proliferative effects on breast ...

    Authors: Dragoslava Zivadinovic, Bahiru Gametchu and Cheryl S Watson
    Citation: Breast Cancer Research 2004 7:R101
  11. Insulin-like growth factor binding protein-3 (IGFBP-3) differentially modulates breast epithelial cell growth through insulin-like growth factor (IGF)-dependent and IGF-independent pathways and is a direct (IG...

    Authors: Sarah B Vestey, Claire M Perks, Chandan Sen, Caroline J Calder, Jeff MP Holly and Zoe E Winters
    Citation: Breast Cancer Research 2004 7:R119
  12. Genetic abnormalities or mutations in premalignant breast lesions may have a role in progression toward malignancy or influence the behaviour of subsequent disease. The A908G (Lys303→Arg) change in the gene en...

    Authors: Michael PA Davies, Penny A O'Neill, Helen Innes and D Ross Sibson
    Citation: Breast Cancer Research 2004 7:R113
  13. This paper summarizes current knowledge on ionizing radiation-associated breast cancer in the context of established breast cancer risk factors, the radiation dose–response relationship, and modifiers of dose ...

    Authors: Cécile M Ronckers, Christine A Erdmann and Charles E Land
    Citation: Breast Cancer Research 2004 7:21
  14. Histopathological features of BRCA1 and BRCA2 tumours have previously been characterised and compared with unselected breast tumours; however, familial non-BRCA1/2 tumours are less well known. The aim of this stu...

    Authors: Hannaleena Eerola, Päivi Heikkilä, Anitta Tamminen, Kristiina Aittomäki, Carl Blomqvist and Heli Nevanlinna
    Citation: Breast Cancer Research 2004 7:R93
  15. Tamoxifen is effective for endocrine treatment of oestrogen receptor-positive breast cancers but ultimately fails due to the development of resistance. A functional screen in human breast cancer cells identifi...

    Authors: Lambert CJ Dorssers, Ton van Agthoven, Arend Brinkman, Jos Veldscholte, Marcel Smid and Koen J Dechering
    Citation: Breast Cancer Research 2004 7:R82
  16. Case-control studies have reported inconsistent results concerning breast cancer risk and polymorphisms in genes that control endogenous estrogen biosynthesis. We report findings from the first family-based as...

    Authors: Habibul Ahsan, Alice S Whittemore, Yu Chen, Ruby T Senie, Steven P Hamilton, Qiao Wang, Irina Gurvich and Regina M Santella
    Citation: Breast Cancer Research 2004 7:R71
  17. We showed in a previous study that prenylated proteins play a role in estradiol stimulation of proliferation. However, these proteins antagonize the ability of estrogen receptor (ER) α to stimulate estrogen re...

    Authors: Philippe Cestac, Guillaume Sarrabayrouse, Claire Médale-Giamarchi, Philippe Rochaix, Patrick Balaguer, Gilles Favre, Jean-Charles Faye and Sophie Doisneau-Sixou
    Citation: Breast Cancer Research 2004 7:R60
  18. Stromal fibroblasts associated with in situ and invasive breast carcinoma differ phenotypically from fibroblasts associated with normal breast epithelium, and these alterations in carcinoma-associated fibroblasts...

    Authors: Andrea Sadlonova, Zdenek Novak, Martin R Johnson, Damon B Bowe, Sandra R Gault, Grier P Page, Jaideep V Thottassery, Danny R Welch and Andra R Frost
    Citation: Breast Cancer Research 2004 7:R46
  19. The aim of the study was to retrospectively define specific features of the technetium-99m pentavalent dimercaptosuccinic acid (99mTc-(V)DMSA) and technetium-99m 2-methoxy isobutyl isonitrile (99mTc-Sestamibi [99...

    Authors: Vassilios Papantoniou, Spyridon Tsiouris, Ekaterini Mainta, Varvara Valotassiou, Michael Souvatzoglou, Maria Sotiropoulou, Lydia Nakopoulou, Dimitrios Lazaris, Androniki Louvrou, Maria Melissinou, Artemis Tzannetaki, Ioannis Pirmettis, John Koutsikos and Cherry Zerva
    Citation: Breast Cancer Research 2004 7:R33
  20. Perinatal events and conditions, notably birth weight, are associated with breast cancer risk in offspring, and correlates of mammary gland mass are predictors of breast cancer risk. These findings may be inte...

    Authors: Dimitrios Trichopoulos, Pagona Lagiou and Hans-Olov Adami
    Citation: Breast Cancer Research 2004 7:13
  21. Systemic chemotherapy is an important part of treatment for breast cancer. We conducted the present study to evaluate whether systemic chemotherapy could produce microsatellite instability (MSI) in the periphe...

    Authors: Fernando LA Fonseca, Aleksandra VL Sant Ana, Israel Bendit, Vitor Arias, Luciano J Costa, Aparecida A Pinhal and Auro del Giglio
    Citation: Breast Cancer Research 2004 7:R28
  22. Several aziridinylbenzoquinone drugs have undergone clinical trials as potential antitumor drugs. These bioreductive compounds are designed to kill cells preferentially within the hypoxia tumor microenvironmen...

    Authors: Yu-Ping Yang, Hsien-Shou Kuo, Hsin-Da Tsai, Yi-Chen Peng and Yuh-Ling Lin
    Citation: Breast Cancer Research 2004 7:R19
  23. The p21-activated kinases signal through a number of cellular pathways fundamental to growth, differentiation and apoptosis. A wealth of information has accumulated at an impressive pace in the recent past, bo...

    Authors: Anupama E Gururaj, Suresh K Rayala and Rakesh Kumar
    Citation: Breast Cancer Research 2004 7:5
  24. Aromatase is the key enzyme involved in oestrogen biosynthesis. Oestrogens not only influence normal development and function but are also implicated in the aetiology and progression of many diseases. Over rec...

    Authors: William R Miller and Alexey Larionov
    Citation: Breast Cancer Research 2004 7:E2
  25. Epidemiologic studies have not shown a strong relationship between blood levels of polychlorinated biphenyls (PCBs) and breast cancer risk. However, two recent studies showed a stronger association among postm...

    Authors: Yu Li, Robert C Millikan, Douglas A Bell, Lisa Cui, Chiu-Kit J Tse, Beth Newman and Kathleen Conway
    Citation: Breast Cancer Research 2004 7:R12
  26. Viruses including Epstein–Barr virus (EBV), a human equivalent of murine mammary tumour virus (MMTV) and human papillomavirus (HPV) have been implicated in the aetiology of human breast cancer. We report the p...

    Authors: Ethel-Michele de Villiers, Robert E Sandstrom, Harald zur Hausen and Charles E Buck
    Citation: Breast Cancer Research 2004 7:R1
  27. The 6th Milan Breast Cancer Conference, held in Milan, Italy, over 16–18 June 2004, was attended by more than 1000 physicians from 60 countries. This report summarizes the highlights of the most interesting co...

    Authors: Roberto Gennari, Saverio Cinieri, Marco Colleoni, Stefano Zurrida, Aron Goldhirsch and Umberto Veronesi
    Citation: Breast Cancer Research 2004 7:E1
  28. Information on the metastasis process in breast cancer patients undergoing primary tumour removal may be extracted from an analysis of the timing of clinical recurrence.

    Authors: Romano Demicheli, Gianni Bonadonna, William JM Hrushesky, Michael W Retsky and Pinuccia Valagussa
    Citation: Breast Cancer Research 2004 6:R689
  29. There is great interest among oncologists concerning what we might learn by examining the pattern of relapse after breast cancer surgery. What you see depends upon how hard you look. Up to now, investigators h...

    Authors: Anthony Howell
    Citation: Breast Cancer Research 2004 6:255
  30. The number of lymph nodes found to be involved in an axillary dissection is among the most powerful prognostic factors in breast cancer, but it is confounded by the number of lymph nodes that have been examine...

    Authors: Vincent Vinh-Hung, Claire Verschraegen, Donald I Promish, Gábor Cserni, Jan Van de Steene, Patricia Tai, Georges Vlastos, Mia Voordeckers, Guy Storme and Melanie Royce
    Citation: Breast Cancer Research 2004 6:R680
  31. Mammary tumors in mice are categorized by using morphologic and architectural criteria. Immunolabeling for terminal differentiation markers was compared among a variety of mouse mammary neoplasms because expre...

    Authors: Igor Mikaelian, Natalie Blades, Gary A Churchill, Karen Fancher, Barbara B Knowles, Janan T Eppig and John P Sundberg
    Citation: Breast Cancer Research 2004 6:R668
  32. The breast tissue is the site of major metabolic conversions of estradiol (E2) mediated by specific cytochromes P450 hydroxylations and methylation by catechol-O-methytransferase. In addition to E2 itself, recent...

    Authors: Chantal Guillemette, Alain Bélanger and Johanie Lépine
    Citation: Breast Cancer Research 2004 6:246
  33. Lysophosphatidic acid (LPA) is a bioactive phospholipid with diverse effects on various cells. It interacts with at least three G-protein-coupled transmembrane receptors, namely LPA1, LPA2 and LPA3, whose expr...

    Authors: Joji Kitayama, Dai Shida, Akihiro Sako, Makoto Ishikawa, Kotaro Hama, Junken Aoki, Hiroyuki Arai and Hirokazu Nagawa
    Citation: Breast Cancer Research 2004 6:R640
  34. Recent evidence suggests a role for progesterone in breast cancer development and tumorigenesis. Progesterone exerts its effect on target cells by interacting with its receptor; thus, genetic variations, which...

    Authors: Immaculata De Vivo, Susan E Hankinson, Graham A Colditz and David J Hunter
    Citation: Breast Cancer Research 2004 6:R636
  35. The cell-cycle checkpoint kinase (CHEK)2 protein truncating mutation 1100delC has been associated with increased risk for breast or prostate cancer. Multiple studies have found an elevated frequency of the 110...

    Authors: Danielle M Friedrichsen, Kathleen E Malone, David R Doody, Janet R Daling and Elaine A Ostrander
    Citation: Breast Cancer Research 2004 6:R629

Annual Journal Metrics

  • 2022 Citation Impact
    7.4 - 2-year Impact Factor
    7.4 - 5-year Impact Factor
    1.764 - SNIP (Source Normalized Impact per Paper)
    2.408 - SJR (SCImago Journal Rank)

    2023 Speed
    20 days submission to first editorial decision for all manuscripts (Median)
    129 days submission to accept (Median)

    2023 Usage 
    2,432,781 downloads
    1,561 Altmetric mentions